Two decades of hard-won progress against HIV may be quietly unraveling — and the mechanism is partly invisible in conventional epidemiology. Intimate partner violence, a social determinant rarely modeled in HIV forecasts, has now been rigorously quantified as a contributor to HIV incidence among women, while projected funding shortfalls cast a shadow over every metric of progress made since 1990.
Drawing on the Global Burden of Disease 2023 framework, this Lancet HIV analysis estimated HIV incidence, prevalence, and mortality across 204 countries and territories from 1990 to 2023, stratified by age and sex. The methodological scope is substantial: input data spanned national HIV programme reports, population-based serosurveys, clinical records, vital registration data, and systematically reviewed literature. Crucially, the study computed population attributable fractions linking intimate partner violence to HIV burden by combining time-series IPV prevalence estimates with effect-size data — a technique that translates a social exposure into a quantifiable disease fraction. A non-parametric stochastic frontier model was then applied to forecast how declining development assistance for health could affect antiretroviral coverage and downstream mortality trajectories through 2030.
This analysis is notable for bridging three domains — epidemiology, social determinants, and health financing — that are typically siloed in the HIV literature. The IPV-attributable fraction approach mirrors methods used successfully in cardiovascular and cancer burden studies, but its application to HIV transmission represents a meaningful methodological advance. The practical implication is significant: interventions targeting gender-based violence may carry dual HIV-prevention benefits that current programming fails to capture. The forecasting component adds urgency, as several high-burden nations remain dependent on external funding for more than 50% of their HIV response. The primary limitation is the model's reliance on indirect data for many low-income settings where IPV and HIV surveillance are both incomplete. Overall, this is a high-impact, policy-proximate contribution that reframes HIV prevention as inseparable from gender equity and sustained financing — an assessment that should inform both program design and advocacy well beyond 2030.